Iranian Doctor Introduces New Angioplasty Method

Saturday, May 3, 2008

Dr. Roxana Mehran, Iranian director of Clinical Research and Data Coordinating & Analysis Center at the Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center (CUMC) has invented a new method for angioplasty in patients undergoing  heart attack which has greatly reduced subsequent risk of bleeding in this group of patients.

The news about the new method first broke out during a scientific symposium held by the US Transcatheter Cardiovascular Therapeutics, known as TCT 2007.

The study carried out by Dr. Roxanna Mehran and her team has proved that using anticoagulant Bivalirudin in patients who have experienced a heart attack can greatly reduce the risk of problems resulting from extensive hemorrhage in those patients up to 24 percent compared to standard methods.

The new method has greatly reduced rate of bleeding after angioplasty, which is usually increased up to 40 percent after this operation.

Test results, which have been supported by Transcatheter Cardiovascular Therapeutics institute, have been assessed over 30 days. Patients undergoing the new operations will be observed for five years with regard to long-term effects of the method.

Dr. Mehran has noted that the research shows that using Bivalirudin is safer than standard angioplasty. The technique reduces risk of hemorrhage in patients, thus decreasing mortality rate after angioplasty.

Dr. Mehran has a long-standing research interest in cardiovascular topics, including intravascular ultrasound, angioplasty and coronary stenting, and has written over 200 publications on these topics as well as a chapter, "Coronary Heart Disease," in the book, Principles and Practice of Interventional Cardiology.

طراحی و توسعه آگاه‌سیستم